Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria
from NIH via Infection Control Today
Researchers at the National Institutes of Health's National Center for Advancing Translational Sciences, Clinical Center and National Institute of Allergy and Infectious Diseases have created a new way to identify drugs and drug combinations that may potentially be useful in combating infections that are resistant to many different antibiotics. They developed an assay to rapidly screen thousands of drugs to determine how effective they were against a variety of types of resistant bacteria.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063